COMPAZINE
LOE ApproachingNDAORALCAPSULE, EXTENDED RELEASE
Approved
Jun 1957
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
COMPAZINE (prochlorperazine) is an oral extended-release capsule small molecule approved in 1957 as a typical antipsychotic and antiemetic agent. The drug's exact current indications are not specified in available data, but it has historically been used for nausea, vomiting, and psychiatric conditions. It works via dopamine receptor antagonism in the chemoreceptor trigger zone and central nervous system.
LOE Approaching
As a legacy product approaching loss of exclusivity with moderate competitive pressure (30), the brand team is likely in transition mode with reduced headcount focused on defensive positioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
COMPAZINE currently supports zero linked job openings, reflecting its status as a legacy, low-growth product with minimal career advancement potential. Professionals joining this product face limited visibility and constrained opportunities for skill-building in modern pharmaceutical operations.
Field Sales RepresentativeBrand Manager
Worked on COMPAZINE at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.